Menu
PacPremier
Magic Hour
Montecito
Loading...
You are here:  Home  >  'Amgen'
Latest

Amgen’s investment in Neumora marks a return to neuroscience research

By   /  Friday, October 15th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Subscriber content, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen’s investment in Neumora marks a return to neuroscience research

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen goes full speed ahead on biosimilar drugs

By   /  Friday, October 15th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, middle, Subscriber content, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen goes full speed ahead on biosimilar drugs

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen invests $100M in startup pursuing brain treatments

By   /  Thursday, October 7th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, left, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen invests $100M in startup pursuing brain treatments

An Amgen-funded biotech company launched Oct. 7, announcing a strategic partnership between the two companies that includes $100 million in funding and global rights to develop and sell some of Amgen’s experimental drugs for neurodegenerative diseases. Thousand Oaks-based Amgen, one of the largest biotech companies in the world, committed $100 million in equity investment to Read More →

Read More →
Latest

Amgen wins patent case

By   /  Tuesday, September 21st, 2021  /  Banking & Finance, Biotech, East Ventura County, Latest news, Law, Tri-County Economy, Tri-County Public Companies  /  No Comments

Thousand Oaks-based Amgen had a big win in court on Sept. 20, as a federal court in New Jersey upheld multiple Amgen patents for its psoriasis treatment, Otezla. Amgen filed a patent infringement lawsuit earlier this year against two companies, Sandoz and Zydus Pharmaceuticals, claiming that their generic versions of Otezla infringed upon at least Read More →

Read More →
Latest

Amgen shrugs off tough quarter, announces plans for new plant in North Carolina

By   /  Friday, August 6th, 2021  /  Banking & Finance, Biotech, Earnings, East Ventura County, Latest news, Subscriber content, Technology, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen shrugs off tough quarter, announces plans for new plant in North Carolina

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen reports Q2 earnings decline

By   /  Tuesday, August 3rd, 2021  /  Banking & Finance, Biotech, Earnings, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen reports Q2 earnings decline

Amgen saw a 73% decline in net earnings in the second quarter of 2021, the company announced Aug. 3. Thousand Oaks-based Amgen, one of the world’s largest biotechnology companies, reported earnings per share of 81 cents for the quarter ended June 30, down from $3.05 per share in the same quarter last year. According to Read More →

Read More →
Latest

Amgen to buy biotech startup TeneoBio

By   /  Tuesday, July 27th, 2021  /  Banking & Finance, Biotech, East Ventura County, Latest news, left, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen to buy biotech startup TeneoBio

Amgen announced July 27 that it plans to buy a privately held Bay Area biotech company called TeneoBio in an all-cash deal worth as much as $2.5 billion. The deal is expected to close in the second half of this year and calls for Amgen to pay $900 million up front for all outstanding shares Read More →

Read More →